in the name of god pneumonia hassan ghobadi md. pulmonologist assistant professor of internal...
Post on 11-Jan-2016
218 Views
Preview:
TRANSCRIPT
In the name of GOD
Pneumonia
Hassan Ghobadi MD. PulmonologistAssistant Professor of Internal MedicineArdabil University of Medical Science
Pneumonia
Definition: Pneumonia is an infection of the pulmonary parenchyma
Classification: Community-acquired (CAP), Health care – associated pneumonia (HCAP)
Hospital-acquired (HAP) Ventilator-associated (VAP)
Pneumonia Over the last decade or two, however, patients
presenting to the hospital have often been found to be infected with multi drug-resistant (MDR) pathogens previously associated with hospital-acquired pneumonia
Widespread use of potent oral antibiotics Earlier transfer of patients out of acute-care hospitals to
their homes Increased use of outpatient IV antibiotic therapy General aging of the population More extensive immunomodulatory therapies
Pathogens in HCAP
Host Defenses
Mucociliary clearance Local antibacterial factors Gag reflex Cough mechanism Normal flora Mucosal barriers Alveolar macrophages Intrinsic opsonizing properties
Pathophysiology Proliferation of microbial pathogens at the alveolar level .
when the capacity of the alveolar macrophages to ingest or kill the microorganisms is exceeded does clinical pneumonia become manifest.
The host inflammatory response, rather than the proliferation of microorganisms, triggers the clinical syndrome of pneumonia
The release of inflammatory mediators, such as interleukin (IL) 1 and tumor necrosis factor (TNF), results in fever
Chemokines, such as IL-8 and granulocyte colony-stimulating factor, stimulate the release of neutrophils
Pathophysiology
Newly recruited neutrophils create an alveolar capillary leak
The capillary leak results in a radiographic infiltrate and rales detectable on auscultation
Hypoxemia results from alveolar filling
Increased respiratory drive in the systemic inflammatory response syndrome (SIRS) leads to respiratory alkalosis
Reductions in lung volume and compliance and the intrapulmonary shunting of blood may cause the patient's death.
Access of microorganisms to the lower respiratory tract
AspirationInhalationContaminated dropletsHematogenous spread Contiguous extension Reactivation of occult infection
Aspiration
The most common route is by aspiration from the oropharynx.
Small-volume aspiration occurs frequently
during sleep.
Patients with decreased levels of consciousness are at risk of aspiration.
The gag reflex and the cough mechanism offer critical protection from aspiration.
Pathology
The initial phase is one of edema, in clinical or autopsy specimens it is so rapidly followed by
Red hepatization phase (The presence of erythrocytes in the cellular intraalveolar exudate )
Gray hepatization (no new erythrocytes are extravasating, and those
already present have been lysed and degraded ) The neutrophil is the predominant cell, fibrin deposition is abundant, and bacteria have disappeared
Resolution, the macrophage is the dominant cell type in the alveolar space, and the debris of neutrophils, bacteria, and fibrin has been cleared
Etiology Streptococcus pneumonia is the most common pathogen.
Typical bacterial pathogens includes : S. pneumoniae, Haemophilus influenzae, and (in selected patients) S. aureus and gram-negative bacilli
such as Klebsiella pneumoniae and Pseudomonas aeruginosa
Atypical organisms include : Mycoplasma pneumoniae, Chlamydophila pneumoniae, and
Legionella spp. as well as respiratory viruses such as influenza viruses, adenoviruses, and respiratory syncytial viruses (RSVs).
The atypical organisms cannot be cultured on standard media, nor can they be seen on Gram's stain
Etiology
Bacteria, fungi, protozoa and viruses (responsible in up to 18% of cases of CAP)
Etiology of pneumonia usually cannot be determined on the basis of clinical presentation.
Treatment directed at a specific pathogen is not superior to empirical therapy.
Identification of an unexpected pathogen allows narrowing of the initial empirical regimen.
Microbial Causes of CAP
Microbial Causes of CAP
Anaerobes play a significant role only when an episode of aspiration has occurred
The combination of (1) An unprotected airway (e.g., in patients with alcohol or
drug overdose or a seizure disorder) and (2) significant gingivitis constitutes the major risk factor
Anaerobic pneumonias are often complicated by abscess formation and significant empyemas or parapneumonic effusions.
Microbial Causes of CAP
It is usually impossible to predict the pathogen in a case of CAP
It is important to consider epidemiologic and risk factors that might suggest certain pathogens
Epidemiology
80% of the CAP cases are treated on an outpatient basis, and ~20% are treated in the hospital
The incidence rates are highest at the extremes of age
The risk factors for CAP in general and for pneumococcal pneumonia in particular have implications for treatment regimens
Risk factors for CAP include alcoholism, immunosuppression, institutionalization, asthma, and an age of >70 years
Risk factors for pneumococcal pneumonia include dementia, seizure disorders, heart failure, cerebrovascular disease, alcoholism, tobacco smoking, chronic obstructive pulmonary disease, and HIV infection
Epidemiology
CA-MRSA infection is more likely in Native Americans, homeless youths, men who have sex with men, military recruits, children in day-care centers, and athletes such as wrestlers.
P. aeruginosa may also infect these patients as well as those with severe structural lung disease.
Risk factors for Legionella infection include diabetes, hematologic malignancy, cancer, severe renal disease, HIV infection, smoking, male gender, and a recent hotel stay or ship cruise .
Epidemiologic Factors
Clinical Manifestations
SYMPTOMS :
Fever & Chill & Sweats Tachycardia Cough (nonproductive or productive ) Blood-tinged sputum (Hemotysis) Short of breath Pleuritic chest pain nausea, vomiting, and diarrhea (up to 20%)
fatigue, headache, myalgias, and arthralgias
Clinical Manifestations
SIGNS :
Inspection : Use of accessory muscles of respiration,
Palpation : Increased or decreased tactile fremitus,
Percussion : Dull to flat ( consolidated lung and pleural fluid ),
Auscultation : Crackles, bronchial breath sounds,
Diagnosis
Is this pneumonia?
(clinical and radiographic methods )
what is the etiology?
( laboratory techniques )
Differential diagnosis
Acute bronchitisAcute exacerbations of COPD Chronic bronchitisHeart failurePulmonary embolismRadiation pneumonitis
Diagnosis
The main purpose of the sputum Gram's stain is to ensure that a sample is suitable for culture
Gram's staining may also help to identify certain pathogens
To be adequate for culture, a sputum sample must have >25 neutrophils and <10 squamous epithelial cells per low-power field
For patients admitted to the ICU and intubated, a deep-suction aspirate or bronchoalveolar lavage sample should be sent to the microbiology laboratory as soon as possible
For suspected tuberculosis or fungal infection, specific stains are available
Cultures of pleural fluid obtained from effusions >1 cm in height on a lateral decubitus CXR
Diagnosis
Blood Cultures: Only ~5–14% of cultures of blood from patients hospitalized with CAP are positive .
Antigen Tests: Detect pneumococcal and Legionella antigens in urine The sensitivity 90% and specificity 99% ,
Serology: A fourfold rise in specific IgM antibody titer,
Imaging
Imaging
Abscess-staph
Pneumonia-lingula
Treatment
2- CURB-65 criteria
1- Confusion (C); 2- Urea >7 mmol/L (U); 3- Respiratory rate 30/min (R); 4- SBP < 90 mmHg or DBP < 60 mmHg (B); 5- Age > 65 years , Patients With a score of 2 should be admitted to the hospital .
Patients With a score of >3 may require admission to an ICU.
Treatment
Site of Care home or hospital
o 1-PSI Points are given for 20 variables, including
age, coexisting illness, and abnormal physical and laboratory findings
class 1 to class 5 Patients in classes 4 and 5 should be
admitted to the hospital
Treatment
pneumococcal resistance to penicillin associated with reduced susceptibility to other drugs, such as macrolides,
tetracyclines, and trimethoprim-sulfamethoxazole (TMP-SMX)
For strains of S. pneumoniae with intermediate levels of resistance, higher doses of the drug should be used
Risk factors for drug-resistant pneumococcal infection include recent antimicrobial therapy, an age of <2 years or >65 years, attendance at day-care centers, recent hospitalization, and HIV infection .
Treatment
CAP due to MRSA resistance to all beta-lactam drugs
Gram-Negative BacilliEnterobacter spp. are resistant to cephalosporins
the drugs of choice are fluoroquinolones or carbapenems
Empirical Treatment (CAP)
Empirical Treatment (CAP)
Treatment
The duration of treatment for CAP : 10–14 days with fluoroquinolones and telithromycin a 5-day course is
sufficient for otherwise uncomplicated CAP
A longer course for patients with bacteremia, metastatic infection, or infection with P. aeruginosa or CA-MRSA
Longer-term therapy should also be considered if initial treatment was ineffective and in most cases of severe CAP
Patients with severe CAP who remain hypotensive despite fluid resuscitation may have adrenal insufficiency
Failure to Improve
Respond to therapy should be reevaluated at about day 3
(1) Is this a noninfectious condition? (2) If this is an infection, is the correct pathogen being targeted? ( e.g., M. tuberculosis or a fungus ) (3) Is this a superinfection with a new nosocomial pathogen? (4) If this is an infection, is the complicated pneumonia (e.g., a lung abscess or empyema )
Noninfectious conditions can mimic pneumonia, including pulmonary edema, pulmonary embolism, lung carcinoma, radiation and hypersensitivity pneumonitis,
and connective tissue disease involving the lungs
Complications
Respiratory failure Shock and multiorgan failure Bleeding diatheses Exacerbation of comorbid illnesses Lung abscess Complicated pleural effusion
If the fluid has a pH of <7, a glucose level of <2.2 m mol/L, and a LDH concentration of >1000 U/L or if bacteria are seen or cultured, then the fluid should be drained; a chest tube is required.( complicated para pneumonic effusion )
Follow-Up & Prevention
Fever usually resolve within 2 days. Leukocytosis usually resolve within 4 days. Physical findings may persist longer. CXR abnormality resolve with in 4–12 Weeks.
The main preventive measure is vaccination.
( for influenza and pneumococcal vaccines )
VAP
Ventilator-Associated Pneumonia
The pathogens and treatment strategies for VAP are more similar to those for HAP than to those for pure CAP
Etiologic agents of VAP include both MDR and non-MDR bacterial pathogens
Microbiologic Causes of VAP
Prevention Strategies for VAP
Prevention Strategies for VAP
Clinical Manifestations of VAP
Are the same as other forms of pneumonia
Fever Leukocytosis Increase in respiratory secretions Pulmonary consolidation on physical examination New or changing radiographic infiltrate Tachypnea, tachycardia, Worsening oxygenation, Increased minute ventilation.
Diagnosis of VAP
No single set of criteria is reliably diagnostic of pneumonia in a ventilated patient
The differential diagnosis of VAP includes: atypical pulmonary edema, pulmonary contusion and/or hemorrhage, hypersensitivity pneumonitis, ARDS, and pulmonary embolism , antibiotic-associated diarrhea, sinusitis, urinary tract infection, pancreatitis, and drug fever.
The recent IDSA/ATS guidelines for HCAP suggest that either approach is clinically valid.
Diagnosis of VAP
Quantitative-Culture Approach
Discriminate between colonization and true infection The diagnostic threshold is 106 cfu/mL The PSB method has a threshold of 103 cfu/mL With sensitive microorganisms, a single antibiotic dose can reduce
colony counts After > 3 days of consistent antibiotic therapy for another infection
prior to suspicion of pneumonia, the accuracy of diagnostic tests for pneumonia is unaffected.
Colony counts above the diagnostic threshold during antibiotic therapy suggest that the current antibiotics are ineffective
Diagnosis of VAP
The Clinical Pulmonary Infection Score (CPIS)
VAP Treatment
Frequent use of beta-lactam drugs, especially cephalosporins, is the major risk factor for infection with MRSA and ESBL-positive strains.
Treatment should be started once diagnostic specimens have been obtained
A negative tracheal-aspirate culture or growth below the threshold for quantitative cultures strongly suggests that antibiotics should be discontinued
Combination therapy with a beta-lactam and an aminoglycoside for Pseudomonas infection
Empirical Antibiotic Treatment (VAP)
Empirical Antibiotic Treatment (VAP)
Prevention (VAP)
Avoid endotracheal intubation or at least to minimize its duration
Minimizing the amount of microaspiration around the ET cuff
Simply elevating the head of the bed (at least 30° but preferably 45°) decreases VAP rates
Emphasis on the avoidance of agents that raise gastric pH
Hospital-Acquired Pneumonia
HAP is similar to VAP The main differences are in the higher
frequency of non-MDR pathogens and the better underlying host immunity
The lower frequency of MDR pathogens As in the management of CAP, specific
therapy targeting anaerobes probably is not indicated unless gross aspiration is a concern.
Blood cultures are infrequently positive (<15% of cases).
top related